| 研究生: |
高宜聲 Kao, Yi-Sheng |
|---|---|
| 論文名稱: |
登革病毒透過integrin-linked kinase誘發suppressor of cytokine signaling 3 的表現進而抑制第一型干擾素訊息傳導 Dengue virus inhibits type I interferon signaling via integrin-linked kinase-mediated suppressor of cytokine signaling 3 induction |
| 指導教授: |
張志鵬
Chang, Chih-Peng |
| 學位類別: |
碩士 Master |
| 系所名稱: |
醫學院 - 微生物及免疫學研究所 Department of Microbiology & Immunology |
| 論文出版年: | 2015 |
| 畢業學年度: | 103 |
| 語文別: | 英文 |
| 論文頁數: | 68 |
| 中文關鍵詞: | 登革病毒 、整合素連接激酶 、第一型干擾素 、細胞素信號傳導抑制因子3 |
| 外文關鍵詞: | Dengue virus, Integrin-linked kinase, Type-I interferon, Suppressor of cytokine signaling 3 |
| 相關次數: | 點閱:83 下載:1 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
登革病毒的感染是全球重要的公衛問題。病毒感染後的症狀包括:輕症的登革熱及嚴重的登革出血熱或是登革休克症候群。然而,目前對抗登革病毒的藥物甚至是疫苗都仍處於臨床試驗階段。先天免疫反應,特別是第一型干擾素(IFN-α/β),是宿主防禦病毒感染的第一道防線。然而已有多篇文獻指出,登革病毒會與許多不同的宿主因子相互作用來逃脫干擾素誘導之免疫反應。不過詳細的機制,尚未完全釐清。整合素連接激酶(integrin-linked kinase, ILK)是一種廣泛表達於細胞中的絲氨酸/蘇氨酸蛋白激酶,具有連接細胞外分子訊息到細胞內信號通路的能力。透過激活整合素連接激酶能夠調節多種細胞功能,包括腫瘤的形成或是調控克沙奇病毒B3型 (Coxsackievirus B3) 的複製。然而,整合素連接激酶與登革病毒間的關係尚未有相關報導。根據我們的實驗數據顯示,在缺乏整合素連接激酶表現的細胞中,其登革病毒產量顯著降低。這顯示整合素連接激酶是登革病毒複製時的重要宿主因子。另外,我們也發現整合素連接激酶並不影響細胞表面與病毒結合的能力,但依然影響登革基因質體 (DENV-replicon) 的表現,表示整合素連接激酶是調控病毒與細胞結合後的複製步驟。另外,實驗結果呈現整合素連接激酶並不會增加登革病毒所誘導產生的第一型干擾素,卻會負向調控第一型干擾素下游的信息傳遞訊號以及抗病毒基因的表達。而且此現象發生的機制是在登革熱病毒感染之下,刺激整合素連接激酶並活化Akt/ERK/NF-κB 這條路徑,誘發產生抑制細胞因子信號3(SOCS3)進而抑制干擾素的訊息傳遞來幫助病毒的複製。根據以上實驗結果,我們推測整合素連接激酶透過負向調控第一型干擾素的信息傳遞訊號,以增進登革病毒複製能力以及疾病的發展。因此,我們的研究揭露的整合素連接激酶過去從未發現的新功能,而整合素連接激酶在未來可作為一個具潛力的抗病毒藥物研發之目標。
Dengue virus (DENV) infection causes a wide range of disease ranging from dengue fever to potentially fatal dengue hemorrhagic fever or dengue shock syndrome. Currently there are no approved vaccines or antiviral drugs against dengue infection. Innate immune responses, particularly type-I interferon (IFN-α/β), are the first lines of defense against viral infections. Unfortunately, DENV interacts with host factors to escape from IFN responses, and the detailed mechanisms are not totally understood. Integrin-linked kinase (ILK) is a widely expressed serine/threonine protein kinase which connects extracellular molecules to intracellular signaling pathways. By activating ILK, a number of cellular functions can be modulated, including tumorigenesis or Coxsackievirus B3 replication. However, the role of ILK in DENV infection remains uncertain. Here, we showed that dengue viral titers are reduced in ILK inhibited cells. Moreover, inhibition of ILK suppresses DENV replicon expression, but no difference is seen in DENV binding in both control and ILK-silenced cells. This indicates that ILK is required for DENV replication after virus entry. Hence, we further investigated whether ILK regulates DENV replication through the IFN pathway. Our results revealed that there is no difference in induction of IFNα/β between DENV-infected control and ILK-silenced cells. Nevertheless, the downstream responses of IFNs, such as STAT1/2 activation or interferon-stimulated genes (ISG) expression, were upregulated in DENV-infected ILK-silenced cells. In contrast, the suppressor of cytokine signaling 3 (SOCS3), which is able to block IFNs signaling is suppressed. This ILK-mediated SOCS3 induction was found to antagonize DENV infection-triggered IFN signaling and ISG expression. Furthermore, we clarified that ILK may activate the Akt/ERK/NF-κB pathway to induce SOCS3 expression that is required for DENV replication. In conclusion, we uncovered a new regulatory role of ILK in IFN signaling, and targeting ILK may be a potential antiviral therapeutic for future drug development.
1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504-507.
2. Ernst T, McCarthy S, Chidlow G, Luang-Suarkia D, Holmes EC, et al. (2015) Emergence of a new lineage of dengue virus type 2 identified in travelers entering Western Australia from Indonesia, 2010-2012. PLoS Negl Trop Dis 9: e0003442.
3. Mustafa MS, Rasotgi V, Jain S, Gupta V (2015) Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India 71: 67-70.
4. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-16.
5. Reyes-del Valle J, Salas-Benito J, Soto-Acosta R, del Angel RM (2014) Dengue virus cellular receptors and tropism. Current Tropical Medicine Reports 1: 36-43.
6. Lee YR, Su CY, Chow NH, Lai WW, Lei HY, et al. (2007) Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES. Virus Res 126: 216-225.
7. Lin YL, Liu CC, Lei HY, Yeh TM, Lin YS, et al. (2000) Infection of five human liver cell lines by dengue-2 virus. J Med Virol 60: 425-431.
8. Rodenhuis-Zybert IA, Wilschut J, Smit JM (2010) Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci 67: 2773-2786.
9. Lai CY, Tsai WY, Lin SR, Kao CL, Hu HP, et al. (2008) Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82: 6631-6643.
10. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, et al. (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108: 717-725.
11. Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3: 13-22.
12. Idrees S, Ashfaq UA (2012) A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan. Genet Vaccines Ther 10: 6.
13. Xu H, Di B, Pan YX, Qiu LW, Wang YD, et al. (2006) Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections. J Clin Microbiol 44: 2872-2878.
14. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A (2003) Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100: 14333-14338.
15. Falgout B, Pethel M, Zhang YM, Lai CJ (1991) Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 65: 2467-2475.
16. Benarroch D, Selisko B, Locatelli GA, Maga G, Romette JL, et al. (2004) The RNA helicase, nucleotide 5'-triphosphatase, and RNA 5'-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core. Virology 328: 208-218.
17. Stern O, Hung YF, Valdau O, Yaffe Y, Harris E, et al. (2013) An N-terminal amphipathic helix in dengue virus nonstructural protein 4A mediates oligomerization and is essential for replication. J Virol 87: 4080-4085.
18. Dalrymple NA, Cimica V, Mackow ER (2015) Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant. MBio 6: e00553-00515.
19. Umareddy I, Chao A, Sampath A, Gu F, Vasudevan SG (2006) Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol 87: 2605-2614.
20. Ackermann M, Padmanabhan R (2001) De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. J Biol Chem 276: 39926-39937.
21. Morrison J, Garcia-Sastre A (2014) STAT2 signaling and dengue virus infection. JAKSTAT 3: e27715.
22. Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, et al. (2005) Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis 11: 742-749.
23. Guzman MG, Harris E (2015) Dengue. Lancet 385: 453-465.
24. Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ (2010) Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 12: 157-164.
25. Wan SW, Lin CF, Yeh TM, Liu CC, Liu HS, et al. (2013) Autoimmunity in dengue pathogenesis. J Formos Med Assoc 112: 3-11.
26. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10: 712-722.
27. Martina BE, Koraka P, Osterhaus AD (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564-581.
28. Falconar AK (2007) Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design. Clin Vaccine Immunol 14: 493-504.
29. Lin CF, Chiu SC, Hsiao YL, Wan SW, Lei HY, et al. (2005) Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol 174: 395-403.
30. Rothman AL (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532-543.
31. Malavige GN, Rostron T, Rohanachandra LT, Jayaratne SD, Fernando N, et al. (2011) HLA class I and class II associations in dengue viral infections in a Sri Lankan population. PLoS One 6: e20581.
32. Chen RF, Wang L, Cheng JT, Chuang H, Chang JC, et al. (2009) Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol 131: 404-409.
33. Jeewandara C, Gomes L, Wickramasinghe N, Gutowska-Owsiak D, Waithe D, et al. (2015) Platelet activating factor contributes to vascular leak in acute dengue infection. PLoS Negl Trop Dis 9: e0003459.
34. Paranjape SM, Harris E (2007) Y box-binding protein-1 binds to the dengue virus 3'-untranslated region and mediates antiviral effects. J Biol Chem 282: 30497-30508.
35. Garcia-Montalvo BM, Medina F, del Angel RM (2004) La protein binds to NS5 and NS3 and to the 5' and 3' ends of Dengue 4 virus RNA. Virus Res 102: 141-150.
36. Tang WC, Lin RJ, Liao CL, Lin YL (2014) Rab18 facilitates dengue virus infection by targeting fatty acid synthase to sites of viral replication. J Virol 88: 6793-6804.
37. Brunetti JE, Scolaro LA, Castilla V (2015) The heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a host factor required for dengue virus and Junin virus multiplication. Virus Res 203: 84-91.
38. Hoang LT, Lynn DJ, Henn M, Birren BW, Lennon NJ, et al. (2010) The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol 84: 12982-12994.
39. Fink J, Gu F, Ling L, Tolfvenstam T, Olfat F, et al. (2007) Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis 1: e86.
40. Lee CJ, Liao CL, Lin YL (2005) Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J Virol 79: 8388-8399.
41. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, et al. (2009) Discovery of insect and human dengue virus host factors. Nature 458: 1047-1050.
42. Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, et al. (2012) Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog 8: e1002780.
43. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, et al. (1996) Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379: 91-96.
44. Dedhar S, Williams B, Hannigan G (1999) Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol 9: 319-323.
45. Hannigan G, Troussard AA, Dedhar S (2005) Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5: 51-63.
46. Hannigan GE, McDonald PC, Walsh MP, Dedhar S (2011) Integrin-linked kinase: not so 'pseudo' after all. Oncogene 30: 4375-4385.
47. Wu C, Dedhar S (2001) Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155: 505-510.
48. Persad S, Attwell S, Gray V, Mawji N, Deng JT, et al. (2001) Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276: 27462-27469.
49. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, et al. (1998) Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci U S A 95: 11211-11216.
50. Legate KR, Montanez E, Kudlacek O, Fassler R (2006) ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7: 20-31.
51. Li R, Liu B, Yin H, Sun W, Yin J, et al. (2013) Overexpression of integrin-linked kinase (ILK) is associated with tumor progression and an unfavorable prognosis in patients with colorectal cancer. J Mol Histol 44: 183-189.
52. Chan J, Ko FC, Yeung YS, Ng IO, Yam JW (2011) Integrin-linked kinase overexpression and its oncogenic role in promoting tumorigenicity of hepatocellular carcinoma. PLoS One 6: e16984.
53. Dai DL, Makretsov N, Campos EI, Huang C, Zhou Y, et al. (2003) Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival. Clin Cancer Res 9: 4409-4414.
54. Tseng PC, Chen CL, Shan YS, Chang WT, Liu HS, et al. (2014) An increase in integrin-linked kinase non-canonically confers NF-kappaB-mediated growth advantages to gastric cancer cells by activating ERK1/2. Cell Commun Signal 12: 69.
55. Ahmed AU, Sarvestani ST, Gantier MP, Williams BR, Hannigan GE (2014) Integrin-linked kinase modulates lipopolysaccharide- and Helicobacter pylori-induced nuclear factor kappaB-activated tumor necrosis factor-alpha production via regulation of p65 serine 536 phosphorylation. J Biol Chem 289: 27776-27793.
56. Kim M, Ogawa M, Fujita Y, Yoshikawa Y, Nagai T, et al. (2009) Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature 459: 578-582.
57. Assi K, Bergstrom K, Vallance B, Owen D, Salh B (2013) Requirement of epithelial integrin-linked kinase for facilitation of Citrobacter rodentium-induced colitis. BMC Gastroenterol 13: 137.
58. Esfandiarei M, Suarez A, Amaral A, Si X, Rahmani M, et al. (2006) Novel role for integrin-linked kinase in modulation of coxsackievirus B3 replication and virus-induced cardiomyocyte injury. Circ Res 99: 354-361.
59. Liu Y, Liu H, Zou J, Zhang B, Yuan Z (2014) Dengue virus subgenomic RNA induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway. Virology 448: 15-25.
60. Lee YR, Huang KJ, Lei HY, Chen SH, Lin YS, et al. (2005) Suckling mice were used to detect infectious dengue-2 viruses by intracerebral injection of the full-length RNA transcript. Intervirology 48: 161-166.
61. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, et al. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
62. Heaton NS, Randall G (2010) Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8: 422-432.
63. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809, table of contents.
64. Sen GC (2001) Viruses and interferons. Annu Rev Microbiol 55: 255-281.
65. Lopusna K, Rezuchova I, Betakova T, Skovranova L, Tomaskova J, et al. (2013) Interferons lambda, new cytokines with antiviral activity. Acta Virol 57: 171-179.
66. Perry AK, Chen G, Zheng D, Tang H, Cheng G (2005) The host type I interferon response to viral and bacterial infections. Cell Res 15: 407-422.
67. Gale M, Jr., Foy EM (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945.
68. Pauli EK, Schmolke M, Wolff T, Viemann D, Roth J, et al. (2008) Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4: e1000196.
69. Zhang JL, Wang JL, Gao N, Chen ZT, Tian YP, et al. (2007) Up-regulated expression of beta3 integrin induced by dengue virus serotype 2 infection associated with virus entry into human dermal microvascular endothelial cells. Biochem Biophys Res Commun 356: 763-768.
70. Wan SW, Lin CF, Lu YT, Lei HY, Anderson R, et al. (2012) Endothelial cell surface expression of protein disulfide isomerase activates beta1 and beta3 integrins and facilitates dengue virus infection. J Cell Biochem 113: 1681-1691.
71. Moon C, Han JR, Park HJ, Hah JS, Kang JL (2009) Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways. Respir Res 10: 18.
72. Tsai TT, Chuang YJ, Lin YS, Chang CP, Wan SW, et al. (2014) Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. PLoS Negl Trop Dis 8: e3320.
73. Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, et al. (2003) IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 17: 488-490.
74. Akhtar LN, Qin H, Muldowney MT, Yanagisawa LL, Kutsch O, et al. (2010) Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J Immunol 185: 2393-2404.
75. Xu X, Zheng J, Zheng K, Hou Y, Zhao F, et al. (2014) Respiratory syncytial virus NS1 protein degrades STAT2 by inducing SOCS1 expression. Intervirology 57: 65-73.
76. Morrison J, Laurent-Rolle M, Maestre AM, Rajsbaum R, Pisanelli G, et al. (2013) Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog 9: e1003265.
77. Silva BM, Sousa LP, Gomes-Ruiz AC, Leite FG, Teixeira MM, et al. (2011) The dengue virus nonstructural protein 1 (NS1) increases NF-kappaB transcriptional activity in HepG2 cells. Arch Virol 156: 1275-1279.
78. Persad S, Dedhar S (2003) The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 22: 375-384.
79. Lee S, Margolin K (2011) Cytokines in cancer immunotherapy. Cancers (Basel) 3: 3856-3893.
80. Yoganathan TN, Costello P, Chen X, Jabali M, Yan J, et al. (2000) Integrin-linked kinase (ILK): a "hot" therapeutic target. Biochem Pharmacol 60: 1115-1119.
81. Liu J, Costello PC, Pham NA, Pintillie M, Jabali M, et al. (2006) Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. J Thorac Oncol 1: 771-779.
82. Lee YR, Hu HY, Kuo SH, Lei HY, Lin YS, et al. (2013) Dengue virus infection induces autophagy: an in vivo study. J Biomed Sci 20: 65.
校內:2020-08-31公開